We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
Sally Beauty Holdings
SBH
$1.51B
| $227 | ﹤0.01% |
25
-3,895
| -99% | -$33.6K |
2023 Q3
7 quarters
|
|
3377
Clover Health Investments
CLOV
$2.54B
| $226 | ﹤0.01% |
81
-50
| -38% | -$164 |
2024 Q4
2 quarters
|
|
3378
Trinity Industries
TRN
$2.08B
| $226 | ﹤0.01% |
8
| – | – |
2017 Q4
30 quarters
|
|
3379
America's Car Mart
CRMT
$11.3M
| $224 | ﹤0.01% |
+4
| New | +$198 |
2025 Q2
0 quarters
|
|
3380
Eldorado Gold
EGO
$8.98B
| $224 | ﹤0.01% |
11
| – | – |
2022 Q1
13 quarters
|
|
3381
Oruka Therapeutics
ORKA
$5.08B
| $224 | ﹤0.01% |
20
| – | – |
2021 Q3
15 quarters
|
|
3382
Gold.com Inc
GOLD
$1.13B
| $222 | ﹤0.01% |
10
+5
| +100% | +$111 |
2025 Q1
1 quarter
|
|
3383
Repay Holdings
RPAY
$332M
| $222 | ﹤0.01% |
46
-342
| -88% | -$1.56K |
2025 Q1
1 quarter
|
|
3384
Virgin Galactic
SPCE
$387M
| $221 | ﹤0.01% |
81
+4
| +5% | +$12 |
2020 Q3
19 quarters
|
|
3385
DELISTED
Couchbase
BASE
| $219 | ﹤0.01% |
+9
| New | +$164 |
2025 Q2
0 quarters
|
|
3386
Conduent
CNDT
$232M
| $216 | ﹤0.01% |
+82
| New | +$193 |
2025 Q2
0 quarters
|
|
3387
Avita Medical
RCEL
$405M
| $212 | ﹤0.01% |
40
| – | – |
2021 Q1
17 quarters
|
|
3388
Investors Title Co
ITIC
$537M
| $211 | ﹤0.01% |
+1
| New | +$224 |
2025 Q2
0 quarters
|
|
3389
Hovnanian Enterprises
HOV
$570M
| $209 | ﹤0.01% |
2
| – | – |
2023 Q3
7 quarters
|
|
3390
KraneShares Global Carbon Strategy ETF
KRBN
$138M
| $208 | ﹤0.01% |
7
| – | – |
2023 Q2
8 quarters
|
|
3391
Gogo Inc
GOGO
$286M
| $206 | ﹤0.01% |
14
| – | – |
2024 Q4
2 quarters
|
|
3392
Grindr
GRND
$2.62B
| $204 | ﹤0.01% |
+9
| New | +$198 |
2025 Q2
0 quarters
|
|
3393
Grupo Aval
AVAL
$5.82B
| $194 | ﹤0.01% |
69
+67
| +3,350% | +$184 |
2019 Q1
25 quarters
|
|
3394
Carter Bankshares
CARE
$696M
| $191 | ﹤0.01% |
+11
| New | +$174 |
2025 Q2
0 quarters
|
|
3395
Central Garden & Pet Co Class A
CENTA
$2.23B
| $188 | ﹤0.01% |
6
| – | – |
2024 Q1
5 quarters
|
|
3396
Pelagos Insurance Capital
PLGO
$2.05B
| $182 | ﹤0.01% |
+11
| New | +$182 |
2025 Q2
0 quarters
|
|
3397
Profound Medical
PROF
$242M
| $177 | ﹤0.01% |
30
-50
| -63% | -$264 |
2022 Q1
13 quarters
|
|
3398
BuzzFeed
BZFD
$90.3M
| $176 | ﹤0.01% |
88
| – | – |
2023 Q4
6 quarters
|
|
3399
DELISTED
Golden Ocean Group
GOGL
| $176 | ﹤0.01% |
+24
| New | +$182 |
2025 Q2
0 quarters
|
|
|
SNRE
3400
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
| $170 | ﹤0.01% |
3
-3
| -50% | -$157 |
2024 Q4
2 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.